The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
Alexander Wissel, Editor in Chief, Investment U
Do you smell that? In some places the smell is subtle, faint. In others it’s a nauseating fog. Make no mistake, what you smell is real and it’s worse than you think.
It’s fear.
The streets are awash with it – from Wall Street to Main Street. Offices are clouded by it. And even worse, the airwaves (be they digital or otherwise) resonate with the sound of fear. Jokes are made around watercoolers, over lunch, and during the workday. But they’re made to break the tension, to ease what has become glaringly apparent.
Ferret’s elf. (Say it fast, or slow – you’ll get it.) Fear itself, has gotten out of hand.
Consider that 98% of metropolitan areas have seen their jobless increase in number, the number of Americans filing for unemployment benefits for the first time is at a 26-year high and Wall Street has been compulsively obsessing over ever latest earnings report.
But these aren’t really bad headlines. Or are they? The fact of the matter is that most of the financial world, and the population that funds them, are looking like shell-shocked veterans rocking themselves in a corner. And if you found that funny – it isn’t.
Like the onset of hypothermia, millions have become numb to the damage in their portfolios. And just like the symptoms of the “cold killer,” investors have become disoriented, irrational and have lost perception of their environment.
In fact we’d be willing to wager that the pessimism/optimism readings are way off. It’s because most investors have become so disassociated to their finances. Like children covering our eyes, millions have turned a blind eye to their portfolio balances.
Too many don’t want to know the extent of the damage. And that’s too bad. It prohibits them from acting them like rational investors, and looking for new opportunities.
And that might be the only way out of this fog.
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed